Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Environmental Management|June 29, 2011
Paving the way for invasive species: road type and the spread of common ragweed (Ambrosia artemisiifolia)Martin Joly, Pascale Bertrand, Roland Y Gbangou, et al.
International Journal of Environmental Research and Public Health|October 16, 2012
Radioactive iodide (131 I-) excretion profiles in response to potassium iodide (KI) and ammonium perchlorate (NH4ClO4) prophylaxisCurtis Harris, Cham Dallas, Edward Rollor, et al.
JACC. Cardiovascular Interventions|November 21, 2009
Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation studyPatrick Gladding, Harvey White, Jamie Voss, et al.
Organic Letters|May 26, 2021
Divergent and Regioselective Synthesis of Pyrazolo[1,5-<i>a</i>]pyridines and Imidazo[1,5-<i>a</i>]pyridinesKatrina M Mennie, Michael H Reutershan, Catherine White, et al.
Antiviral Research|July 23, 2014
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolismChandrav De, Dongmei Liu, Bo Zheng, et al.
Canadian Journal of Occupational Therapy. Revue Canadienne D'Ergotherapie|July 26, 2022
Psychotherapy Within Occupational Therapy Literature: A Scoping ReviewCarrie Anne Marshall, Michelle Murphy, Kristina Marchiori, et al.
BMJ Open|October 6, 2018
Research priorities in fragility fractures of the lower limb and pelvis: a UK priority setting partnership with the James Lind AllianceMiguel A Fernandez, Laura Arnel, Jenny Gould, et al.
BMJ Open|December 18, 2019
Research priorities for the management of broken bones of the upper limb in people over 50: a UK priority setting partnership with the James Lind AllianceWarren J Sheehan, Mark A Williams, Zoe Paskins, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2014
The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: lead optimizationTony Siu, Sathyajith E Kumarasinghe, Michael D Altman, et al.
BMJ (Clinical Research Ed.)|April 3, 2015
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialDavid Pace, Ameneh Khatami, Jennifer McKenna, et al.
Pageof 5